title: [Clinical description of effectiveness of pioglitazone in a complex therapy of patients with ischemic heart disease on background of metabolic syndrome].
abstract: The results suggest that addition of pioglitazone in a complex treatment therapy of patients with ischemic heart disease on background of metabolic syndrome was not associated with an increased ischemic heart disease (IHD) risk and improved the clinical course of IHD, increased effectiveness of standard therapy for patients with IHD and metabolic syndrome.
authors.forename: N I
authors.initials: NI
authors.lastname: Vinnik
authors.forename: I P
authors.initials: IP
authors.lastname: Kaĭdashev
mesh_terms: D000368:Aged; D017311:Amlodipine / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood / Q000652:urine; D017298:Bisoprolol / Q000008:administration & dosage; D001794:Blood Pressure; D015992:Body Mass Index; D004338:Drug Combinations; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D009765:Obesity / Q000150:complications; D000077205:Pioglitazone; D011758:Pyrroles / Q000008:administration & dosage; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D004338:Drug Combinations; D006538:Heptanoic Acids; D011758:Pyrroles; D045162:Thiazolidinediones; D017311:Amlodipine; D000069059:Atorvastatin; D007548:Isosorbide Dinitrate; D001241:Aspirin; D000077205:Pioglitazone; D017298:Bisoprolol